TARGET GROUP INC.

CBDY ·Healthcare, Drug Manufacturers - General
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Jun 2026 Mar 2026 Dec 2025 Sep 2025 Jun 2025 Mar 2025 Dec 2024 Sep 2024
Revenue $1.4M $879.4K $735.2K $499.7K $1.2M $1.4M $1.9M $541.1K
Cost of Revenue $752.5K $687.7K $448.0K $235.3K $500.3K $629.6K $777.4K $173.0K
Gross Profit $628.3K $191.8K $287.2K $264.4K $745.4K $770.8K $1.1M $368.1K
Gross Margin 45.5% 21.8% 39.1% 52.9% 59.8% 55.0% 58.1% 68.0%
Operating Expenses
Research & Development
SG&A Expense
Operating Income $-239.8K $-550.3K $-552.3K $-479.4K $-219.8K $-108.2K $216.0K $-529.0K
Operating Margin -17.4% -62.6% -75.1% -95.9% -17.6% -7.7% 11.6% -97.8%
Interest Expense $9 $9
Pretax Income $-239.8K $-550.4K $-552.3K $-479.4K $-219.8K $-108.2K $216.0K $-529.0K
Income Tax Expense
Net Income $-239.8K $-550.4K $-552.3K $-479.4K $-219.8K $-108.2K $216.0K $-529.0K
Net Margin -17.4% -62.6% -75.1% -95.9% -17.6% -7.7% 11.6% -97.8%
EPS (Basic) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
EPS (Diluted) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Shares Outstanding (Basic) 617.0M 617.0M 617.0M 617.0M 617.0M 617.0M 617.0M 617.0M
Shares Outstanding (Diluted) 617.0M 617.0M 617.0M 617.0M 617.0M 617.0M 727.2M 617.0M
Dividends Per Share
← Newer Page 1 of 6 Older →